Tamoxifen to prevent cancer in pancreatic cysts
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether tamoxifen, a hormone-blocking pill, can prevent pancreatic cysts from turning into cancer in people who are not having surgery to remove the cyst right away.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have a type of pancreatic cyst called a mucinous cystic neoplasm (MCN) that is not cancerous and is not being removed right away
- You have not taken tamoxifen or similar drugs in the past 5 years
- You have not had a blood clot, stroke, or certain eye or uterine conditions
- You are willing to use two forms of birth control if you or your partner could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
This study looks at the genetic material (genomics) of pancreatic cysts to better understand them and possibly improve diagnosis or treatment. By studying fluid or tissue from your cyst, researchers hope to find markers that can help guide care.
This trial tests whether tamoxifen, a hormone therapy drug, can shrink or slow down advanced solid pseudopapillary tumors of the pancreas (SPTP) that have estrogen and progesterone receptors. It may be an option for people whose tumors cannot be removed by surgery or have come back after other treatments.
This study tests whether tamoxifen (a medication used for breast cancer) is safe and tolerable for adults with cystic fibrosis who cannot take CFTR modulators. It is an early trial focusing on safety, but it may help open new treatment options.
This trial tests a new way to treat pancreatic cysts called IPMNs by putting a needle through an endoscope into the cyst and delivering chemotherapy directly. The goal is to see if this approach is feasible and safe before a larger study.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
Hear when a new Pancreatic Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.